Effect of antidepressants on brain-derived neurotrophic factor (BDNF) release from platelets in the rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 8, 2010, Pages 1450-1454

  Watanabe, Kimihiko ^a   Hashimoto, Eri ^a   Ukai, Wataru ^a   Ishii, Takao ^b   Yoshinaga, Toshihiro ^a   Ono, Takafumi ^a   Tateno, Masaru ^a   Watanabe, Ippei ^a   Shirasaka, Tomohiro ^a   Saito, Satoshi ^a   Saito, Toshikazu ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Antidepressant; BDNF; Biomarker; Depression; Platelet

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FLUVOXAMINE; MILNACIPRAN; PAROXETINE; SERTRALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; DRUG EFFECT; IN VITRO STUDY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RAT; THROMBOCYTE;

ANIMALS; ANTIDEPRESSIVE AGENTS; BLOOD PLATELETS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENOUS; MALE; RATS; RATS, WISTAR;

EID: 78649525282     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.07.036     Document Type: Article

References (25)

1. Aydemir O., Deveci A., Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:261-265.
2. Belmaker R.H. The future of depression psychopharmacology. CNS Spectr 2008, 13:682-687.
3. Campbell S., Macqueen G. The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci 2004, 29:417-426.
4. Doris A., Ebmeier K., Shajahan P. Depressive illness. Lancet 1999, 354:1369-1375.
5. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006, 59:1116-1127.
6. Fujimura H., Altar C.A., Chen R., Nakamura T., Nakahashi T., Kambayashi J., et al. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 2002, 87:728-734.
7. Gur T.L., Conti A.C., Holden J., Bechtholt A.J., Hill T.E., Lucki I., et al. cAMP response element-binding protein deficiency allows for increased neurogenesis and a rapid onset of antidepressant response. J Neurosci 2007, 27:7860-7868.
8. Hayashi A., Kasahara T., Kametani M., Kato T. Attenuated BDNF-induced upregulation of GABAergic markers in neurons lacking Xbp1. Biochem Biophys Res Commun 2008, 376:758-763.
9. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002, 109:143-148.
10. Karege F., Schwald M., Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 2002, 328:261-264.
11. Karege F., Bondolfi G., Gervasoni N., Schwald M., Aubry J.M., Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005, 57:1068-1072.
12. Kuipers S.D., Trentani A., Den Boer J.A., Ter Horst G.J. Molecular correlates of impaired prefrontal plasticity in response to chronic stress. J Neurochem 2003, 85:1312-1323.
13. Lee B.H., Kim Y.K. Reduced platelet BDNF level in patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:849-853.
14. Matrisciano F., Bonaccorso S., Ricciardi A., Scaccianoce S., Panaccione I., Wang L., et al. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6months treatment with sertraline, escitalopram, or venlafaxine. J Psychiatr Res 2009, 43:247-254.
15. Mossner R., Mikova O., Koutsilieri E., Saoud M., Ehlis A.C., Muller N., et al. Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry 2007, 8:141-174.
16. Pan W., Banks W.A., Fasold M.B., Bluth J., Kastin A.J. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998, 37:1553-1561.
17. Paris B.L., Ogilvie B.W., Scheinkoenig J.A., Ndikum-Moffor F., Gibson R., Parkinson A. In vitro inhibition and induction of human liver cytochrome p450 enzymes by milnacipran. Drug Metab Dispos 2009, 37:2045-2054.
18. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109.
19. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003, 54:70-75.
20. Siuciak J.A., Lewis D.R., Wiegand S.J., Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 1997, 56:131-137.
21. Smith M.A., Makino S., Kvetnansky R., Post R.M. Effects of stress on neurotrophic factor expression in the rat brain. Ann NY Acad Sci 1995, 771:234-239.
22. Ventimiglia R., Mather P.E., Jones B.E., Lindsay R.M. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci 1995, 7:213-222.
23. Vermetten E., Vythilingam M., Southwick S.M., Charney D.S., Bremner J.D. Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Biol Psychiatry 2003, 54:693-702.
24. Yang Z.F., Ho D.W., Lau C.K., Tam K.H., Lam C.T., Poon R.T., et al. Platelet activation during tumor development, the potential role of BDNF-TrkB autocrine loop. Biochem Biophys Res Commun 2006, 346:981-985.
25. Yoshimura R., Mitoma M., Sugita A., Hori H., Okamoto T., Umene W., et al. Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1034-1037.